Skip to main content
STVN
NYSE Life Sciences

Stevanato Cuts 2027 Outlook to Low-Single-Digit Growth, Shares Plunge 29%

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$13.38
Mkt Cap
$3.669B
52W Low
$12.05
52W High
$27
52W Position info
11% above low
Off High info
50% below high
Rel. Volume info
8.5× avg
Market data snapshot near publication time

STVN is trading near its 52-week low of $12.05 (11% above the low) on elevated volume (8.5× avg).

Summary

Stevanato guided 2027 growth to low single digits and said GLP-1 sales have fallen to 17-18% of revenue as one client cut syringe volumes. Shares dropped 28.57% to $14.10 on the news. William Blair downgraded the stock to Market Perform from Outperform. Separately, company officers are under investigation over possible misleading statements to investors, though no lawsuit has been filed. The guidance cut lands just two days after Q3 results showed 8% organic revenue growth to €326.1 million and a 27.2% adjusted EBITDA margin, so the demand signal from the GLP-1 client is the key change to the thesis.

At the time of this announcement, STVN was trading at $13.38 on NYSE in the Life Sciences sector, with a market capitalization of approximately $3.7B. The 52-week trading range was $12.05 to $27.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

STVN - Latest Insights

STVN
Nov 04, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $14.16
Real-time Price: $15.65 info
Change: +$1.49 (+11%) info
Market Cap: $4.273B info
STVN
Nov 03, 2026, 4:15 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $14.46
Real-time Price: $15.65 info
Change: +$1.19 (+8%) info
Market Cap: $4.273B info
STVN
Nov 03, 2026, 4:05 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $14.10
Real-time Price: $15.65 info
Change: +$1.55 (+11%) info
Market Cap: $4.273B info
STVN
Nov 03, 2026, 6:30 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $19.74
Real-time Price: $15.65 info
Change: -$4.09 (-21%) info
Market Cap: $4.273B info
STVN
Aug 06, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $20.30
Real-time Price: $15.65 info
Change: -$4.65 (-23%) info
Market Cap: $4.273B info